Start a free trial
Menu

AMedP-7.6

AMedP-7.6 commander's guide to CBRN medical support

Commanders and the CJFC-level Medical Advisors, Medical Directors and medical staff who plan and coordinate medical support to CBRN defensive operations

AMedP-7.6 is NATO's guide setting out, for commanders and CJFC-level medical staff, the command and planning decisions that medical support to CBRN defensive operations requires.

Edition
A
Published
2018-02

What it is

AMedP-7.6 is the NATO Allied Medical Publication that guides a Combined Joint Force Commander (CJFC) and the medical staff around that commander through the command and planning decisions that medical support to chemical, biological, radiological and nuclear (CBRN) defensive operations requires. It is written at the operational level, for the headquarters that plans and runs an operation, not for the personnel who deliver care at the point of wounding: the guide itself says it "contrasts with AMedP-7.1, which considers medical support in MTFs and at the tactical unit level." Nations record their agreement to use AMedP-7.6 in STANAG 2873. The edition in front of us is Edition A, Version 1, promulgated in February 2018, effective on receipt, and it replaces the earlier AMedP-7, Edition D.

The guide sits beneath NATO's wider medical and CBRN doctrine rather than standing alone. It is subordinate to the overarching joint medical doctrine for CBRN operations, AJMedP-7, and it builds its own planning on the general medical planning process set out in AJMedP-1. It works from the CBRN defence concept in AJP-3.8 and the medical command and control structure defined in the overarching Allied medical support doctrine, AJP-4.10.

Who is responsible for what

The guide is explicit about roles, and about the fact that they are not held by the same person. The Medical Advisor is "the senior medical staff officer in a formation headquarters who is responsible for ensuring that the commander and his staff are properly aware of the health and medical implications of their actions." The Medical Director is "the functional head of the medical services in a formation or theatre of operations," and may also hold the Medical Advisor role for a senior commander. The Medical Coordination Cell (MEDCC) is "the executing body of the medical organization," working under the Medical Director's direction to coordinate multinational, joint and multifunctional medical issues. Above them, commanders "determine medical support requirements for the mission and coordinate medical planning and support" within the Combined Joint Operations Area (CJOA), and are typically granted coordinating authority to redistribute medical assets as the mission requires.

The five areas of CBRN defence with a medical dimension

The guide organises CBRN medical support around five areas that NATO's own CBRN defence concept identifies as having a medical dimension: detection; information management; physical protection; medical countermeasures and casualty care; and hazard management. A further chapter covers the medical logistics that cuts across all five. For each area, the guide names "those medical issues and tasks that require command decisions or direction," leaving the clinical and technical detail behind each to the family of publications it points to, principally AMedP-7.1 for medical management and ATP-3.8.1 for CBRN defence on operations generally.

Detection covers how medical health and disease surveillance contributes to recognising that a CBRN incident has occurred, and the command decisions that follow from it. Information management covers how medical information is collected, protected and shared with the commander and with CBRN defence staff, drawing on the definition of information management in AJP-6. Physical protection covers the operational and medical considerations around the use of protective equipment, a responsibility the guide describes as fundamentally operational and logistical rather than medical. Medical countermeasures and casualty care covers the command decisions around when and how countermeasures are used and how casualties are managed, without prescribing the countermeasures or the clinical content itself. Hazard management covers the containment measures taken to limit the operational impact of an incident, and the command and staff coordination that requires.

Planning across three phases

The guide structures planning around three phases of a CBRN incident: before it happens, during it, and after it. Pre-incident planning is the most detailed of the three, and covers medical and non-medical support and resource considerations a commander's staff should work through as part of the wider operational risk assessment. During an incident, the priority for Medical Advisors and Medical Directors is collecting, assessing and disseminating information to support the force. Post-incident, the guide describes updating courses of action on the basis of the information gathered, and reassessing plans for their continued relevance.

A concrete planning artefact the guide describes is a decision authorities matrix: a document that identifies the types of decisions that may need to be made in response to a CBRN incident, the authorities responsible for making them, and the conditions under which each decision should be made. Producing one, and keeping the roles above filled and understood, is what NATO's own exercise and readiness processes actually check for.

What it does not cover

AMedP-7.6 is explicit about its own limits. It sets no clinical treatment protocols, training standards, casualty-estimation methodology or laboratory requirements: those are the subject of other publications in the family it points to, principally AMedP-7.1 at the tactical level. It does not itself define what equipment, medicines or specific procedures a medical unit uses; it defines who decides, who coordinates, and when.

How we help

AMedP-7.6 is a command and planning guide for a NATO headquarters, not a specification a supplier builds a product against, and its subject, medical support to CBRN defensive operations, is capability ComplyTrain does not provide. The medical planning, the command decisions and the CBRN response itself are done by the commander and the medical chain of command the guide describes, not by software, and ComplyTrain is not a substitute for that expertise or that capability.

Where a fit exists, it is narrow and indirect. An organisation contracted to support some part of a NATO deployment, for example providing a service, training or equipment that has to interoperate with this command structure, can use ComplyTrain to hold the internal procedures, records and evidence trail that show it meets whatever its own contract or quality clause requires, the same way it would for any other customer requirement. That is a step removed from AMedP-7.6 itself: ComplyTrain does not map to the guide's roles or planning artefacts, and it does not perform, plan or evidence the medical or CBRN work the guide describes.

What applies, and which of the wider family of NATO medical and CBRN publications comes with it, is set by the specific contract or tasking in front of a supplier, not by this guide on its own. See the standards explorer for what sits alongside AMedP-7.6, or talk to us about the evidence trail for the part of the work that is yours to hold.

Standards it references

Questions

Is AMedP-7.6 mandatory?

Not on its own. Nations record their agreement to use it in STANAG 2873, and a nation can ratify a STANAG with reservations, so whether it binds a specific headquarters or contractor depends on that nation's own implementation and on what a contract or tasking actually invokes.

What is the difference between AMedP-7.6 and AMedP-7.1?

AMedP-7.6 is written for the operational-level commander and the medical staff around them: who decides what, and who coordinates with whom. AMedP-7.1 covers medical management at Medical Treatment Facilities and the tactical unit level, and AMedP-7.6 says explicitly that it contrasts with AMedP-7.1 in this way.

Is there a certification for AMedP-7.6?

No. The guide names no certification scheme, and nothing in it describes a third party auditing a company against it. It is NATO command doctrine, applied by a deployed headquarters and checked through NATO's own exercise and readiness processes, not an external audit a company or its quality system could hold.

Who is AMedP-7.6 written for?

Commanders and, specifically, the Medical Advisors, Medical Directors and medical staff working at the level of a Combined Joint Force Commander. It is not written for the personnel who deliver medical care in the field, and it is not written for equipment or product suppliers.

What edition of AMedP-7.6 is current?

Edition A, Version 1, promulgated in February 2018, effective on receipt. It replaces the earlier AMedP-7, Edition D, which nations were to destroy under their own document-destruction procedures.